Stock listing
NMTC Stock Price, News, Filings & Events — Neuroone Medical Technologies Corporation
Selected listing: NMTC · NASDAQ · USD · US
This page tracks Neuroone Medical Technologies Corporation's NMTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NMTC:NASDAQ. NMTC:NASDAQ is the stock-level entry point for investors researching Neuroone Medical Technologies Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroone Medical Technologies Corporation (ticker: NMTC) is a public company based in the United States, focusing on innovative medical technologies. With a market capitalization of approximately $16.5 million, Neuroone is dedicated to developing solutions for neurological disorders. The company aims to improve patient outcomes through advanced medical devices and therapies.
- Ticker
- NMTC:NASDAQ
- Asset type
- Stock
- Market cap
- $18.5M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- NASDAQ
- Currency
- USD
Neuroone Medical Technologies Corporation NMTC:NASDAQ stock context
This page tracks Neuroone Medical Technologies Corporation's NMTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NMTC:NASDAQ. NMTC:NASDAQ is the stock-level entry point for investors researching Neuroone Medical Technologies Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Neuroone Medical Technologies Corporation (ticker: NMTC) is a public company based in the United States, focusing on innovative medical technologies. With a market capitalization of approximately $16.5 million, Neuroone is dedicated to developing solutions for neurological disorders. The company aims to improve patient outcomes through advanced medical devices and therapies.
Latest news from Neuroone Medical Technologies Corporation
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time
August 3, 2026
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
July 30, 2026
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
July 28, 2026
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
July 16, 2026
NeuroOne(R) Added to Russell Microcap(R) Index
June 29, 2026
Research Neuroone Medical Technologies Corporation
Neuroone Medical Technologies Corporation investor report
Review AI stock analysis and investor report context for NMTC:NASDAQ.
Neuroone Medical Technologies Corporation company profile
View the public company page for Neuroone Medical Technologies Corporation on 6ix.
Neuroone Medical Technologies Corporation news
Read company news and market updates connected to Neuroone Medical Technologies Corporation.
Neuroone Medical Technologies Corporation investor events
Find investor webinars, events, and replay context for Neuroone Medical Technologies Corporation.